RAPT Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 07 2020 - 8:00AM
RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage
immunology-based biopharmaceutical company focused on
discovering, developing and commercializing oral small molecule
therapies for patients with significant unmet needs in oncology and
inflammatory diseases, today announced that Brian Wong, M.D.,
Ph.D., its President and CEO, will present a corporate update and
company overview at the 38th Annual J.P. Morgan Healthcare
Conference on Thursday, January 16th at 11:30 a.m. Pacific Time in
San Francisco.
A live webcast and audio archive of the presentation may be
accessed on the RAPT Therapeutics website
at https://investors.rapt.com/events-and-presentations. Please
connect to the website 10 minutes prior to the presentation to
ensure adequate time for any software downloads that may be
necessary to listen to the webcast.
About RAPT Therapeutics, Inc.RAPT
Therapeutics is a clinical stage immunology-based
biopharmaceutical company focused on discovering, developing and
commercializing oral small molecule therapies for patients with
significant unmet needs in oncology and inflammatory diseases.
Utilizing its proprietary discovery and development engine, the
Company rapidly develops highly selective small molecules designed
to modulate the critical immune drivers underlying these diseases.
RAPT has a diversified portfolio with near-term clinical milestones
expected in 2020. RAPT has discovered and advanced two unique drug
candidates, FLX475 and RPT193, each targeting C-C motif chemokine
receptor 4, for the treatment of cancer and inflammation,
respectively. The Company is also pursuing a range of targets,
including general control nonderepressible 2 (GCN2) and
hematopoietic progenitor kinase 1 (HPK1), that are in the discovery
stage of development.
Media Contact: Angela Bitting media@rapt.com(925) 202-6211
Investor Contact: Sylvia Wheeler swheeler@wheelhouselsa.com
RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Apr 2023 to Apr 2024